One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1016/j.annonc.2020.10.069
Copy DOI Journal: Annals of Oncology |  Publication Date: Nov 1, 2020 |
 Citations: 7 |  License type: publisher-specific-oa |
Affiliation: Dana-Farber Cancer Institute, Peter MacCallum Cancer Centre, Centre Eugène Marquis, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Aichi Cancer Center, Queen Mary University of London, Roche (Switzerland), New York University Langone Medical Center, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center49MO IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
